DEF: Klotho Neurosciences Seeks Reverse Split, Boosts Equity Pool

Sentiment:

Proxy Statement


Klotho Neurosciences, Inc. will hold a Special Meeting to vote on a reverse stock split to meet Nasdaq listing requirements and an increase in its equity incentive plan to attract and retain talent.

Delay expectedThe Adjournment Proposal allows the Company to adjourn the Special Meeting to a later date if there are insufficient votes to approve the reverse stock split or the equity incentive plan amendment, or to establish a quorum, which would delay the implementation of these proposals.
Capital raiseThe reverse stock split, by reducing outstanding shares without reducing authorized shares, will increase the number of shares available for issuance, which the Board believes is appropriate to fund future operations and potentially finance future acquisitions.The amendment to the 2024 Equity Incentive Plan, increasing the shares available for equity awards, provides a mechanism for future compensation that can also be a component of strategic transactions or talent acquisition, indirectly supporting capital allocation strategies.
Worse than expectedThe Company received a delinquency notification from Nasdaq on September 19, 2025, for not maintaining a minimum bid price of $1.00 per share, indicating a decline in stock price below exchange requirements.

Summary

  • A Special Meeting of Stockholders is scheduled for February 13, 2026, to address three key proposals.
  • Proposal 1 seeks approval for an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio between one-for-2 and one-for-50, at the Board's discretion.
  • The primary goal of the reverse stock split is to increase the per share market price to meet The Nasdaq Capital Market's minimum bid price requirement of $1.00, following a delinquency notification received on September 19, 2025.
  • Proposal 2 requests approval to amend the Company's 2024 Equity Incentive Plan, increasing the number of shares available for issuance thereunder to 10,000,000.
  • This increase is intended to enable the Company to continue attracting and retaining key service providers and align their interests with stockholders, as the current reserved shares (1,668,126) represent only approximately 2% of outstanding shares.
  • Proposal 3 is for the approval of adjourning the Special Meeting, if necessary, to solicit additional proxies or establish a quorum.
  • As of January 12, 2026, Klotho Neurosciences had 73,536,722 shares of common stock issued and outstanding.
  • The fair market value of a share of common stock as of the Record Date (January 13, 2026) was $0.18 (pre-Reverse Stock Split-adjusted basis).

Sentiment

Score: 4

Explanation: The filing addresses critical issues (Nasdaq non-compliance) with necessary, but often negatively perceived, corporate actions (reverse stock split). While the equity plan increase is positive for talent, the underlying reason for the reverse split points to challenges. The overall sentiment is cautious, reflecting the defensive nature of the primary proposal.

Positives

  • The proposed reverse stock split aims to help the Company regain compliance with Nasdaq's minimum bid price requirement, preventing potential delisting.
  • Increasing the per share price could make the common stock more attractive to a broader range of investors, including institutional investors, who often have policies against investing in low-priced stocks.
  • The amendment to the 2024 Equity Incentive Plan will provide 10,000,000 shares for awards, essential for attracting, motivating, and retaining key employees, consultants, and Board members.
  • Equity incentives align the interests of service providers with those of stockholders, promoting long-term growth and stockholder value creation.

Negatives

  • The need for a reverse stock split indicates the Company's common stock is trading below Nasdaq's minimum bid price, reflecting a challenging market perception or underlying performance issues.
  • Reverse stock splits can carry a negative perception among investors and analysts, potentially leading to further stock price declines even after the split.
  • There is no assurance that the reverse stock split will result in a sustained increase in the market price or that the Company will maintain Nasdaq compliance.
  • The reverse stock split will reduce the total number of outstanding shares, which may decrease liquidity and lead to a smaller number of market makers.
  • Stockholders owning 'odd lots' (less than 50 shares) after the split may face incrementally higher trading costs.
  • The increase in the equity incentive plan, while necessary for talent, will result in approximately 13.3% dilution to existing stockholders based on current outstanding shares.

Risks

  • The expected benefits of the reverse stock split, such as increased trading price and Nasdaq compliance, may not be realized or maintained.
  • The market price of common stock after the reverse stock split may not increase proportionally to the split ratio, potentially leading to a decrease in overall market capitalization.
  • The reduction in outstanding shares could decrease the liquidity of the common stock and lead to fewer market makers.
  • Stockholders may own 'odd lots' (less than 50 shares) after the split, which can be more difficult to sell or incur higher transaction costs.
  • The increase in authorized but unissued shares resulting from the reverse stock split could have an anti-takeover effect, although this is not the stated purpose.
  • The issuance of additional shares under the amended 2024 Equity Incentive Plan will have a dilutive effect on the ownership of existing stockholders.

Future Outlook

The Company expects the reverse stock split, if approved and implemented, to increase its per share market price to regain and maintain compliance with Nasdaq's minimum bid price requirement. The increased share pool for the equity incentive plan is anticipated to enable the Company to attract and retain key talent, fostering long-term growth and stockholder value. The Board does not foresee needing another increase in the equity plan shares until December 31, 2026.

Management Comments

  • The Board of Directors recommends a vote FOR approval of the amendment to the Company's Second Amended and Restated Certificate of Incorporation to effect a reverse stock split.
  • The Board recommends a vote FOR approval of the amendment to the Company's 2024 Equity Incentive Plan.
  • The Board of Directors recommends a vote FOR approval of the adjournment proposal.

Industry Context

The Company's need for a reverse stock split is driven by its failure to meet The Nasdaq Capital Market's minimum bid price requirement of $1.00 per share, a common challenge for companies with low stock prices. Many institutional investors and brokerage firms have internal policies that restrict or discourage investment in low-priced stocks, making a higher share price desirable for broader market appeal and liquidity. The proposed increase in the equity incentive plan is a standard practice across industries to attract and retain talent through performance-based compensation, aligning employee interests with shareholder value.

Comparison to Industry Standards

  • The Company's current market price of $0.18 per share falls below the $1.00 minimum bid price requirement of The Nasdaq Capital Market, a common threshold for continued listing on major exchanges, indicating a performance or market perception challenge compared to peers maintaining compliance.
  • The Company notes that many brokerage houses and institutional investors have internal policies prohibiting or discouraging investment in low-priced stocks, a widespread industry practice that impacts the liquidity and investor base for companies like Klotho Neurosciences.
  • The observation that brokers' commissions on low-priced stocks generally represent a higher percentage of the stock price than on higher-priced stocks is a general industry characteristic affecting transaction costs for individual investors in low-priced securities.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to Certificate of IncorporationProposal to amend the Second Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's outstanding common stock at an exchange ratio between one-for-2 to one-for-50.Upon filing of Certificate of Amendment with Delaware Secretary of State (if approved and implemented by Board, no later than June 30, 2026).Aims to increase per share price for Nasdaq compliance and make stock more attractive to investors. Will reduce outstanding shares and proportionally adjust equity awards. Could have an anti-takeover effect due to increased unissued authorized shares.
Amendment to Equity Incentive PlanProposal to amend the Company's 2024 Equity Incentive Plan to increase the number of shares of Common Stock available and reserved for issuance thereunder to 10,000,000 shares.Immediately upon stockholder approval (if approved).Enhances the Company's ability to attract, motivate, and retain key service providers through equity compensation, aligning their interests with stockholders. Will result in approximately 13.3% dilution to existing stockholders.

Related Party Transactions

  • None of the Company's executive officers or directors has any interest in the matters to be acted upon at the Special Meeting, except to the extent of their ownership of shares of Common Stock or securities exercisable or convertible into Common Stock.

Stakeholder Impact

  • Shareholders: Will experience a reduction in the number of shares held (reverse stock split) but maintain the same percentage ownership (except for fractional share rounding). Face potential dilution from the increased equity incentive plan. May benefit from increased stock price and Nasdaq compliance, but also face risks of negative perception and reduced liquidity.
  • Employees, Consultants, and Board Members: Will benefit from an increased pool of shares available for equity incentive awards, enhancing their compensation and aligning their long-term interests with the Company's success.
  • Nasdaq: The proposed reverse stock split is a direct response to Nasdaq's minimum bid price requirement, aiming to maintain the Company's listing status.

Next Steps

  • Hold the Special Meeting of Stockholders on February 13, 2026, to vote on the proposed amendments.
  • If approved, the Board will determine the specific reverse stock split ratio (between 1-for-2 and 1-for-50) and implement it by June 30, 2026.
  • If approved, the amendment to the 2024 Equity Incentive Plan will be effective immediately, subject to share availability.
  • If a quorum is not present or proposals do not receive sufficient votes, the meeting may be adjourned to solicit additional proxies.

Key Dates

DateDescription
March 16, 2021Original Certificate of Incorporation filed (under name Redwoods Acquisition Corp).
February 17, 2022Certificate of amendment filed, increasing authorized shares.
April 12, 2024Company's 2024 Equity Incentive Plan adopted by Board and approved by stockholders.
June 21, 2024Second Amended and Restated Certificate of Incorporation filed.
September 19, 2025Company received delinquency notification from Nasdaq regarding non-compliance with the $1.00 minimum bid price requirement.
December 31, 2025Date used for calculating percentage of outstanding shares for the 2024 Equity Incentive Plan amendment.
January 9, 2026Board approved the amendment to the 2024 Equity Incentive Plan.
January 12, 2026Date for which security ownership information is provided (73,536,722 shares outstanding).
January 13, 2026Record date for the Special Meeting of Stockholders.
January 23, 2026Date of the Notice of Special Meeting and Proxy Statement.
January 27, 2026Anticipated mailing commencement date for proxy materials.
February 5, 2026Deadline to request timely delivery of documents in advance of the Special Meeting.
February 13, 2026Date of the Special Meeting of Stockholders.
March 29, 2034Termination date of the 2024 Equity Incentive Plan, if not terminated earlier by the Board.
June 30, 2026Latest date by which the Board must implement the reverse stock split, if approved.

Recommendation

hold

The filing outlines necessary corporate actions to address Nasdaq listing compliance and enhance talent retention. While a reverse stock split often carries negative connotations, it is a critical step to maintain exchange listing, which is fundamental for investor access and liquidity. The increase in the equity incentive plan is a standard practice for growth-oriented companies to align management and employee interests. These are structural adjustments rather than direct indicators of immediate financial performance. A seasoned investor would likely 'hold' to observe the effectiveness of these actions in stabilizing the stock price, maintaining Nasdaq listing, and how the company leverages its enhanced equity compensation to drive future growth and financial results.

Keywords

Reverse Stock Split, Equity Incentive Plan, Nasdaq Listing Compliance, Stockholder Meeting, Corporate Governance, Stock Dilution, Executive Compensation, Share Price, Capital Market

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.